Where The Buying Ran Strongest: 26 Large Cap Stocks At 52-Week Highs
Strength in large-cap names persists even as the broader market shows weakness.
Eli Lilly (LLY), with a market value of about $1105.2 billion, leads a list of 26 Large Cap stocks at their 52-week highs. This strength from individual names comes as the S&P 500 has returned -1.2% over the last month. The central question is whether these new highs are built on durable business performance or just price action.
The names below offer a first look.
Every Name On The List
- 16 Stocks Just Touched 52-Week Lows
- 37 S&P 500 Stocks Just Made New 52-Week Highs
- 66 Small Cap Stocks Hit 52-Week Highs On Wednesday
- Where The Buying Ran Strongest: 33 Mid Cap Stocks At 52-Week Highs
- Market Movers | Winners: CRNX, CLRO, TVRD | Losers: KIDZ, EDBL, WHLR
- S&P 500 Movers | Winners: CTSH, OXY, CBOE | Losers: INTC, TER, GNRC
The table below shows the 10 largest of the 26 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| LLY | $1,105.2 Bil | 3.0% | 0.5% | 9.8% | 59.4% |
| JPM | $921.4 Bil | 0.4% | 3.4% | 9.6% | 16.8% |
| JNJ | $643.7 Bil | 3.1% | 3.4% | 17.1% | 75.6% |
| UNH | $388.8 Bil | 2.4% | 2.0% | 8.6% | 42.5% |
| RY | $291.3 Bil | 0.5% | 2.1% | 7.2% | 62.4% |
| UNP | $167.9 Bil | 0.2% | 3.8% | 7.3% | 22.5% |
| WELL | $166.3 Bil | 2.1% | 4.3% | 18.3% | 57.9% |
| BMO | $126.3 Bil | 1.2% | 1.2% | 7.9% | 63.3% |
| BNY | $105.7 Bil | 2.0% | 6.3% | 6.2% | |
| PNC | $102.9 Bil | 0.3% | 3.0% | 11.9% | 33.6% |
Eli Lilly’s new high is matched by its business expansion.
The pharmaceutical giant’s stock price is accompanied by revenue that grew 47.4% over the last twelve months. Eli Lilly (LLY) also posts an operating margin of 47.3%. This contrasts with another large name on the list, Johnson & Johnson (JNJ). While JNJ has gained 17.1% over the last month, its revenue grew 7.9% over the last twelve months with an operating margin of 26.8%. Both trade at high multiples, with LLY at 43.7 times trailing earnings and JNJ at 30.6 times.
A high price is a question, not a verdict.
A 52-week high signals that a stock is at its strongest price of the last year. While strong trends can continue, a disciplined investor treats the price level as a prompt for new diligence. The task is to check whether the underlying business fundamentals justify the market’s current valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
One more pattern worth noticing: 14 of the 26 names are Financials stocks. When a whole group is making new highs together, a financials ETF like XLF is one way to own the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.